share_log

HC Wainwright & Co. Reiterates Buy on OKYO Pharma, Maintains $4 Price Target

Benzinga ·  Dec 5, 2023 06:49

HC Wainwright & Co. analyst Yi Chen reiterates OKYO Pharma (NASDAQ:OKYO) with a Buy and maintains $4 price target.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment